Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TJO-083 (diquafosol) in Dry Eye Diseases
NCT06427031Phase 3Completed
- Sponsor
- Taejoon Pharmaceutical Co., Ltd.
- Start
- Jul 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of diquafosol in dry eye syndrome (DED), sponsored by Taejoon Pharmaceutical Co., Ltd.. Started Jul 2023; status: completed.
02
Drugs
diquafosol
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT06427031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06427031.